Author:
Pesce Elisa,Manfrini Nicola,Cordiglieri Chiara,Santi Spartaco,Bandera Alessandra,Gobbini Andrea,Gruarin Paola,Favalli Andrea,Bombaci Mauro,Cuomo Alessandro,Collino Federica,Cricrì Giulia,Ungaro Riccardo,Lombardi Andrea,Mangioni Davide,Muscatello Antonio,Aliberti Stefano,Blasi Francesco,Gori Andrea,Abrignani Sergio,De Francesco Raffaele,Biffo Stefano,Grifantini Renata
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by beta-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has rapidly spread across the globe starting from February 2020. It is well established that during viral infection, extracellular vesicles become delivery/presenting vectors of viral material. However, studies regarding extracellular vesicle function in COVID-19 pathology are still scanty. Here, we performed a comparative study on exosomes recovered from the plasma of either MILD or SEVERE COVID-19 patients. We show that although both types of vesicles efficiently display SARS-CoV-2 spike-derived peptides and carry immunomodulatory molecules, only those of MILD patients are capable of efficiently regulating antigen-specific CD4+ T-cell responses. Accordingly, by mass spectrometry, we show that the proteome of exosomes of MILD patients correlates with a proper functioning of the immune system, while that of SEVERE patients is associated with increased and chronic inflammation. Overall, we show that exosomes recovered from the plasma of COVID-19 patients possess SARS-CoV-2-derived protein material, have an active role in enhancing the immune response, and possess a cargo that reflects the pathological state of patients in the acute phase of the disease.
Subject
Immunology,Immunology and Allergy
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献